Abstract In contrast to drugs established to treat neonatal seizures, levetiracetam shows little neurotoxicity in experimental animal models and has good safety records in adults and children. Here, we present results from a survey on the off-label use of levetiracetam in newborn infants among neonatologists and pediatric neurologists in German university hospitals.

Klinische Pädiatrie

Report; Off-Label Use; Hospitals, University - statistics & numerical data; Humans; Piracetam - adverse effects; Anticonvulsants - therapeutic use; Infant, Newborn, Diseases - drug therapy; Anticonvulsants - adverse effects; Spasms, Infantile - drug therapy; Health Surveys; Piracetam - therapeutic use; Piracetam - analogs & derivatives; Drug Utilization - statistics & numerical data; Germany; Infant, Newborn; Index Medicus; Germany; epilepsy; Antiepileptikum; antiepileptic drug; Epilepsie; Neugeborenenkrampfanfälle; neonatal seizures; levetiracetam

MEDLINE; Medline Complete; MEDLINE with Full Text; PubMed; MEDLINE (Ovid); TOXLINE; MEDLINE - Academic; Environmental Sciences and Pollution Management